GlassScriptPhysician profile
Howard S Zipin
NPI 1417939539
$25,627.79
in general payments reported to CMS, 2019-2025
91 companies · $2,964 in 2025
The $2,964 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,650 · 2020: $1,490 · 2021: $5,990 · 2022: $2,341 · 2023: $2,807 · 2024: $4,385 · 2025: $2,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,923 · Consulting Fee: $1,925 · Education: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,922.89 |
| Consulting Fee | $1,925.00 |
| Education | $308.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,082.04 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $2,419.76 | 2020-2024 | Xpovio |
| E.R. Squibb & Sons, L.L.C. | $2,321.94 | 2019-2025 | Opdivo, Krazati, Augtyro |
| Beigene USA, INC. | $2,064.90 | 2020-2024 | Brukinsa, Tevimbra |
| Astrazeneca Pharmaceuticals LP | $1,249.26 | 2019-2025 | Calquence, Enhertu, Imfinzi |
| Janssen Biotech, INC. | $908.66 | 2019-2025 | Tecvayli, Darzalex, Erleada |
| Daiichi Sankyo INC. | $828.12 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Merck Sharp & Dohme LLC | $740.55 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Genentech USA, INC. | $728.27 | 2019-2025 | Venclexta, Polivy, Columvi |
| Astellas Pharma US INC | $553.21 | 2019-2025 | Xtandi, Padcev, Vyloy |
| Pfizer INC. | $536.66 | 2019-2025 | |
| Genzyme Corporation | $501.89 | 2019-2025 | |
| Incyte Corporation | $494.95 | 2019-2025 | Monjuvi, Jakafi, Pemazyre |
| Takeda Pharmaceuticals U.S.A., INC. | $427.87 | 2019-2025 | Fruzaqla, Ninlaro, Alunbrig |
| Celgene Corporation | $403.69 | 2019-2025 | Reblozyl |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $380.69 | 2019-2025 | Padcev, Adcetris, Tukysa |
| Pharmacyclics LLC, An Abbvie Company | $357.72 | 2019-2023 | Imbruvica, Epkinly |
| Bayer Healthcare Pharmaceuticals INC. | $355.72 | 2019-2025 | |
| Abbvie INC. | $333.86 | 2019-2025 | Lupron Depot, Venclexta |
| Genmab U.S., INC. | $332.28 | 2021-2025 | Tivdak, Epkinly |
| Lilly USA, LLC | $331.59 | 2019-2024 | Verzenio, Retevmo, Jaypirca |
| Amgen INC. | $328.54 | 2019-2023 | Kyprolis, Xgeva, Vectibix |
| Glaxosmithkline, LLC. | $318.44 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Eisai INC. | $281.27 | 2019-2025 | |
| Gilead Sciences, INC. | $229.53 | 2021-2025 | Trodelvy |
| Ipsen Biopharmaceuticals, INC | $208.26 | 2019-2025 | Onivyde, Somatuline Depot |
| Sobi, INC | $192.79 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.05 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $158.64 | 2019-2023 | |
| Rigel Pharmaceuticals, INC. | $153.14 | 2019-2024 | Rezlidhia, Tavalisse |
| Alexion Pharmaceuticals, INC. | $144.08 | 2019-2025 | Ultomiris |
| Adc Therapeutics America, INC. | $142.40 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $140.96 | 2019-2025 | Libtayo |
| Blueprint Medicines Corporation | $137.90 | 2021-2024 | Ayvakit |
| Exelixis INC. | $125.75 | 2019-2024 | Cabometyx |
| Emd Serono, INC. | $122.67 | 2019-2024 | Bavencio |
| Pharmacosmos Therapeutics INC. | $106.70 | 2021-2025 | Monoferric |
| Array Biopharma INC | $106.44 | 2019-2025 | Mektovi, Braftovi, Lorbrena |
| Tersera Therapeutics LLC | $97.09 | 2020-2023 | Zoladex |
| Stemline Therapeutics INC. | $89.08 | 2021-2025 | Orserdu |
| Beone Medicines USA, INC. | $86.35 | 2025 | Brukinsa |
| Dendreon Pharmaceuticals LLC | $81.68 | 2019-2023 | Provenge |
| Puma Biotechnology, INC. | $73.38 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $70.18 | 2021-2023 | Myrisk |
| Morphosys, US INC. | $67.94 | 2022-2023 | Monjuvi |
| Epizyme, INC. | $65.81 | 2021-2022 | |
| Ge Healthcare | $64.94 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $58.49 | 2022-2025 | Givlaari |
| Sun Pharmaceutical Industries INC. | $58.37 | 2021-2023 | Odomzo, Yonsa |
| Legend Biotech USA INC. | $57.34 | 2025 | Carvykti |
| Kite Pharma, INC. | $56.95 | 2021-2025 | Yescarta |
| Aveo Pharmaceuticals, INC. | $54.74 | 2021-2024 | Fotivda |
| Sanofi-Aventis U.S. LLC | $53.90 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $51.70 | 2023 | Empaveli |
| Acrotech Biopharma INC. | $50.80 | 2024-2025 | Beleodaq |
| Janssen Pharmaceuticals, INC | $48.39 | 2019-2023 | Xarelto |
| Tesaro, INC. | $46.64 | 2019 | |
| Foundation Medicine, INC. | $46.60 | 2019-2022 | |
| Taiho Oncology, INC. | $45.40 | 2019-2023 | |
| Progenics Pharmaceuticals, INC. | $45.18 | 2022-2023 | Pylarify |
| Servier Pharmaceuticals LLC | $45.04 | 2025 | |
| Welch Allyn | $44.36 | 2021 | |
| Adaptive Biotechnologies Corporation | $44.14 | 2022-2025 | Clonoseq |
| Tempus Ai, INC | $43.66 | 2024 | |
| Kyowa Kirin, INC. | $43.44 | 2022-2025 | |
| Telix Pharmaceuticals | $41.77 | 2024-2025 | Illuccix |
| Novocure INC. | $40.30 | 2025 | Optune Lua (Novottf-200t) |
| Teva Pharmaceuticals USA, INC. | $37.25 | 2019-2020 | |
| Dova Pharmaceuticals | $36.23 | 2020-2021 | |
| Mirati Therapeutics, INC. | $34.74 | 2023 | Krazati |
| Global Blood Therapeutics, INC. | $30.90 | 2020-2021 | |
| Mylan Institutional INC. | $30.86 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $30.36 | 2019 | |
| Immunogen, INC. | $29.96 | 2024 | Elahere |
| Pharmaessentia USA Corporation | $28.95 | 2024 | Besremi |
| Myovant Sciences INC. | $25.08 | 2021-2022 | |
| Shire North American Group INC | $24.25 | 2019 | |
| Sumitomo Pharma America, INC. | $23.27 | 2025 | Orgovyx |
| Springworks Therapeutics, INC. | $21.84 | 2024 | Ogsiveo |
| Coherus Oncology, INC. | $21.10 | 2022 | |
| Verastem, INC. | $19.87 | 2019 | |
| Fortovia Therapeutics, INC. | $18.77 | 2019 | |
| Verity Pharmaceuticals INC. | $17.74 | 2021 | |
| Innate Pharma, INC | $16.51 | 2020 | |
| Amag Pharmaceuticals, INC. | $16.06 | 2020 | |
| Clovis Oncology, INC. | $13.53 | 2019 | |
| Secura Bio, INC. | $13.39 | 2020 | |
| Deciphera Pharmaceuticals INC. | $12.14 | 2022 | |
| Aurobindo Pharma USA, INC. | $12.13 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $11.85 | 2022 | |
| Akcea Therapeutics, INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
Brukinsa $2,058Enhertu $522Keytruda $407Calquence $249Epkinly $241Tecvayli $236Darzalex $225Imbruvica $216Carvykti $211Venclexta $199Monjuvi $196Kisqali $183Tivdak $182Reblozyl $168Jemperli $167Zejula $167Erleada $165Lynparza $156Jakafi $146Talvey $141Injectafer $138Trodelvy $135Nubeqa $133Lenvima $129Verzenio $125Imfinzi $124Scemblix $123Fruzaqla $113Onivyde $110Vonjo $103Libtayo $103Tukysa $97.02Padcev $96.34Tagrisso $93.85Xtandi $93.74Stivarga $92.88Pemazyre $91.73Cabometyx $91.18Xpovio $90.76Ayvakit $87.06Sarclisa $83.89Illuccix $83.54Fabhalta $82.11Wayrilz $80.32Polivy $77.87Ibrance $76.63Adcetris $74.91Ninlaro $73.77Alunbrig $72.26Somatuline Depot $71.88Ultomiris $70.70Bosulif $69.55Vitrakvi $67.33Doptelet $66.67Elrexfio $64.49Keytruda Qlex $64.16Datroway $61.27Xofigo $59.65Mektovi $58.76Braftovi $58.76Krazati $57.80Columvi $56.31Lunsumio $56.31Monoferric $55.06Elahere $54.94Opdivo $53.60Orgovyx $52.53Retevmo $52.38Jaypirca $52.38Empaveli $51.70Beleodaq $50.80Tecentriq $50.54Nerlynx $47.34Tasigna $44.90Talzenna $43.82Lorbrena $42.53Optune Lua (Novottf-200t) $40.30Tavalisse $40.30Rezlidhia $40.30Jevtana $39.18Fotivda $38.92Orserdu $37.70Promacta $37.33Yescarta $37.09Ojjaara $36.13Niktimvo $34.84Besponsa $34.82Pluvicto $33.96Givlaari $30.28Zynyz $29.98Clonoseq $29.22Besremi $28.95Lutathera $28.45Tecentriq Hybreza $27.03Lupron Depot $26.91Mekinist $25.46Pylarify $25.35Vyloy $23.89Zoladex $23.68Poteligeo $23.52
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Zipin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.